Cargando…
Respuesta: Tiroiditis subaguda después de la vacuna anti SARS-CoV-2 (Ad5-nCoV)
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818376/ https://www.ncbi.nlm.nih.gov/pubmed/35153354 http://dx.doi.org/10.1016/j.eimc.2022.01.009 |
| _version_ | 1784645815405379584 |
|---|---|
| author | Flores-Rebollar, Armando |
| author_facet | Flores-Rebollar, Armando |
| author_sort | Flores-Rebollar, Armando |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8818376 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88183762022-02-07 Respuesta: Tiroiditis subaguda después de la vacuna anti SARS-CoV-2 (Ad5-nCoV) Flores-Rebollar, Armando Enferm Infecc Microbiol Clin Carta al Editor Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2022 2022-02-07 /pmc/articles/PMC8818376/ /pubmed/35153354 http://dx.doi.org/10.1016/j.eimc.2022.01.009 Text en © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Carta al Editor Flores-Rebollar, Armando Respuesta: Tiroiditis subaguda después de la vacuna anti SARS-CoV-2 (Ad5-nCoV) |
| title | Respuesta: Tiroiditis subaguda después de la vacuna anti SARS-CoV-2 (Ad5-nCoV) |
| title_full | Respuesta: Tiroiditis subaguda después de la vacuna anti SARS-CoV-2 (Ad5-nCoV) |
| title_fullStr | Respuesta: Tiroiditis subaguda después de la vacuna anti SARS-CoV-2 (Ad5-nCoV) |
| title_full_unstemmed | Respuesta: Tiroiditis subaguda después de la vacuna anti SARS-CoV-2 (Ad5-nCoV) |
| title_short | Respuesta: Tiroiditis subaguda después de la vacuna anti SARS-CoV-2 (Ad5-nCoV) |
| title_sort | respuesta: tiroiditis subaguda después de la vacuna anti sars-cov-2 (ad5-ncov) |
| topic | Carta al Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818376/ https://www.ncbi.nlm.nih.gov/pubmed/35153354 http://dx.doi.org/10.1016/j.eimc.2022.01.009 |
| work_keys_str_mv | AT floresrebollararmando respuestatiroiditissubagudadespuesdelavacunaantisarscov2ad5ncov |